Literature DB >> 17517341

Remote Active Monitoring in Patients with Heart Failure (RAPID-RF): design and rationale.

Leslie A Saxon1, John P Boehmer, Stacey Neuman, Christopher M Mullin.   

Abstract

BACKGROUND: Heart failure (HF) ambulatory disease management programs appear to offer the greatest benefit to HF patients at highest risk, defined as having New York Heart Association (NYHA) functional Class III or IV symptoms. The Latitude Patient Management System is the first HF management tool to use wireless telemetry present in a cardiac resynchronization therapy defibrillator (CRT-D) device that is linked to remotely collect blood pressure and weight measures, permitting a single transmission reporting device data. Potential advantages of this system include ease of data transmissions, correlation among measures of HF status, arrhythmic events, and device performance. However, the use and ultimate utility of these combined features for patient management are untested. METHODS AND
RESULTS: The Remote Active Monitoring in Patients with Heart Failure (RAPID-RF) study is a multicenter registry that will enroll up to 1000 patients on the Latitude Patient Management System from approximately 100 centers. The primary objective is to examine physician responses to Latitude Active Monitoring data alerts by assessing alert-related medical interventions. Minimum follow-up will be 3 months after implant with a maximum follow-up time of 24 months after implant.
CONCLUSIONS: The RAPID-RF study will provide important preliminary data on how remotely collected HF and arrhythmic surveillance data alter the management of HF patients with CRT-D devices.

Entities:  

Mesh:

Year:  2007        PMID: 17517341     DOI: 10.1016/j.cardfail.2006.12.004

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  7 in total

1.  ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs).

Authors:  Sergio Dubner; Angelo Auricchio; Jonathan S Steinberg; Panos Vardas; Peter Stone; Josep Brugada; Ryszard Piotrowicz; David L Hayes; Paulus Kirchhof; Günter Breithardt; Wojciech Zareba; Claudio Schuger; Mehmet K Aktas; Michal Chudzik; Suneet Mittal; Niraj Varma
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

Review 2.  Advances in remote monitoring of implantable pacemakers, cardioverter defibrillators and cardiac resynchronization therapy systems.

Authors:  Werner Jung; Andreas Rillig; Ralf Birkemeyer; Tomislav Miljak; Udo Meyerfeldt
Journal:  J Interv Card Electrophysiol       Date:  2008-09-27       Impact factor: 1.900

Review 3.  Past, present, and future of CRT.

Authors:  Angelo Auricchio; François Regoli
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

4.  Innovations in the development of cardiac resynchronization therapy devices with defibrillation capability-the Boston Scientific experience.

Authors:  Patrick Yong; Erdulfo Deperalta
Journal:  J Cardiovasc Transl Res       Date:  2008-09-09       Impact factor: 4.132

Review 5.  Remote patient management using implantable devices.

Authors:  Colin Movsowitz; Suneet Mittal
Journal:  J Interv Card Electrophysiol       Date:  2011-02-17       Impact factor: 1.900

6.  Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes.

Authors:  Massimo Santini; Renato P Ricci; Maurizio Lunati; Maurizio Landolina; Giovanni B Perego; Maurizio Marzegalli; Milena Schirru; Chiara Belvito; Roberto Brambilla; Giuseppe Guenzati; Serena Gilardi; Sergio Valsecchi
Journal:  J Interv Card Electrophysiol       Date:  2008-10-31       Impact factor: 1.900

7.  Design of the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study to assess the ability of remote monitoring to treat and triage patients more effectively.

Authors:  Maurizio Marzegalli; Maurizio Landolina; Maurizio Lunati; Giovanni B Perego; Alessia Pappone; Giuseppe Guenzati; Carlo Campana; Maria Frigerio; Gianfranco Parati; Antonio Curnis; Irene Colangelo; Sergio Valsecchi
Journal:  Trials       Date:  2009-06-18       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.